Synthesis and Antiviral Properties of Ethyl(3-ethyladamant-1-yl)carbamate


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The new adamantine derivative ethyl(3-ethyladamant-1-yl)carbamate was found to have high antiviral activity against herpes simplex virus and vaccinia viruses, as well as adenovirus (EC50 = 0.62, 5.15, and 48.5 μg/ml respectively). Activity against the herpesvirus was demonstrated in experiments in various cell cultures using different virus strains, including a variant resistant to acycloguanosine (ACG). Simultaneous application of ethyl(3-ethyladamant-1-yl)carbamate and ACG increased the inhibition of herpesvirus reproduction in cell cultures and decreased the mortality of laboratory animals with experimental herpesvirus neuroinfection as compared with the use of each substance alone. 3-Ethyladamant-1-yl)carbamate was a low-toxicity compound, did not inhibit DNAsynthesis in uninfected cell cultures, and its acute intragastric LD50 for white mice was 1831.8 mg/kg.

Sobre autores

Yu. Klimochkin

Samara State Technical University

Autor responsável pela correspondência
Email: orgchem@samgtu.ru
Rússia, 244 Molodogvardeiskaya Street, Samara, 443100

I. Moiseev

Samara State Technical University

Email: orgchem@samgtu.ru
Rússia, 244 Molodogvardeiskaya Street, Samara, 443100

M. Leonova

Samara State Technical University

Email: orgchem@samgtu.ru
Rússia, 244 Molodogvardeiskaya Street, Samara, 443100

S. Nikolaeva

Republican Scientific Applied Center for Epidemiology and Microbiology, Ministry of Health of the Republic of Belarus

Email: orgchem@samgtu.ru
Belarus, 23 Filimonov Street, Minsk, 220114

E. Boreko

Republican Scientific Applied Center for Epidemiology and Microbiology, Ministry of Health of the Republic of Belarus

Email: orgchem@samgtu.ru
Belarus, 23 Filimonov Street, Minsk, 220114

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media New York, 2017